To the Editor, Triclosan (2,4,4′-trichloro-2′-hydroxydiphenyl ether) is a synthetic, broad-spectrum antimicrobial agent used extensively in various healthcare products and household consumer goods such as soap, detergents, toothpastes, and other products. Triclosan (TCS) was first introduced in the 1960s for the use in clinical applications. Reports have suggested that TCS is absorbed in human skin and oral mucosa;
and it has been detected in various human tissues and fluids. 1, 2 In addition, toxicological studies have shown that TCS exposure induces physiological perturbations in animals and in humans. 4, 5 Recently, a risk assessment undertaken by the US Food and Drug Administration (FDA) revealed that TCS was present in the urine samples of 75% of the US general population, and, in 2016, the FDA banned its use in soap products. 3, 5 Over the last 6 years, a number of studies have identified a positive correlation between the urinary TCS level and sensitization to food, aeroallergens, and perturbations in asthmatic patients. 1, 6, 7 In addition, an experimental study has
shown that the topical application of TCS enhances allergic response in ovalbumin (OVA)-sensitized mice, 8 suggesting that TCS might play an adjuvant role in the allergic response to environmental allergens.
However, there has still been insufficient evidence to support a relationship between perturbation of the gut microbiome and allergic manifestations in relation to TCS exposure. The aim of this study was to evaluate the in vivo TCS-induced alteration of the gut microbiome and aggravation of asthmatic airway response in aeroallergensensitized mice.
We performed two independent experiments. In the first experiment, wild type BALB/cJ mice (n = 36) were randomly divided into 6 groups of six animals, including normal mice group rRNA gene sequencing was performed following procedures described by Shen et al. 9 Data are presented as the mean ± SEM, and statistical comparisons among the treatment groups were performed with the use of one-way ANOVA test followed by the nonparametric Tukey test, whereas the abundance of bacterial genes was compared using Student's t test (SPSS software package). Detailed methodology is provided in Supporting informations.
As results, simultaneous exposure of wild-type mice to TCS and Der f induced:
1). An increase in the production of anti-Der f IgE, IL-4, and IL-13
( Figure 1D -B-E), which resulted in the aggravation of airway hyperresponsiveness in aeroallergen-exposed wild type mice ( Figure 1A ), whereas these changes were not observed in non-sensitized mice;
2). Increased collagen deposition and infiltration of inflammatory cells (eosinophils) in the lungs of aeroallergen-exposed wild type mice as shown in Figure 1C ; F I G U R E 1 Induction of airway inflammation and hyperresponsiveness, eosinophil count, serum anti-Der f IgE level, and BAL fluid levels of IL-4 and IL-13 in wild-type BALB/c mice. Airway hyperresponsiveness was induced using acetylcholine (ACh). Normal mice group received PBS, whereas the allergen-exposed mice groups received either Der f only (Der f group), Der f + dieselexhausted particles (asthma group), or Der f + triclosan (wildtype + Der f + 5 mg/kg triclosan group, wild-type + Der f + 50 mg/ kg triclosan group, wild-type + Der f + 500 mg/kg triclosan group).
In wild-type mice, AHR was significantly increased by simultaneous exposure to triclosan and Der f in comparison with wild-type + Der f mice (P < 0.01). The area under the curve (AUC) for the doseresponse to ACh (range: 62.5-2000 mg/kg); ## P < 0.01 vs wildtype + Der f group (A). In addition, significantly higher serum antiDer f IgE titers were observed in all triclosan-treated sensitized mice groups (5, 50, 500 mg/kg) as compared with wild-type + Der f group (P < 0.01, P < 0.05, and P < 0.05, respectively) (B). Furthermore, the number of eosinophils in BALF was significantly higher in of triclosan-treated mice groups (50 mg/kg triclosan and 500 mg/kg triclosan) than in wild-type + Der f mice group (P < 0.05) (C). The BALF levels of IL-4 (D) and IL-13 (D) (5, 50, 500 mg/kg) in triclosantreated mice were significantly higher than those in wild-type + Der f mice (P < 0.05, P < 0.05, and P < 0.01, respectively). The results represent the mean ± SEM of data from each group; 
